The concept of the “third era” in medical affairs highlights a significant transformation: What was once a traditional scientific support function has now evolved into a strategic leadership role alongside commercial and R&D, actively shaping organizational success for pharma companies.
In this era, equipping medical affairs teams with medical analytics capabilities is a strategic imperative. The convergence of real-world data, digital health innovation, AI and evolving healthcare delivery models have the potential to transform how medical affairs operates.
To take advantage of this unprecedented opportunity, ZS has developed a framework for medical analytics that evaluates the current state of maturity compared to the industry. We have also outlined a roadmap to advance an organization’s progress toward measurable, scalable and sustainable medical impact.
Download the white paper here to learn how best-in-class medical affairs organizations are using analytics to improve decision-making, strategy and patient outcomes.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
